Renal Cancer - Results from #3200

Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis. November 11, 2019

ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer. November 11, 2019

MicroRNA-200 family expression analysis in metastatic clear cell renal cell carcinoma patients. November 8, 2019

Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study. November 8, 2019

Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma. November 8, 2019

Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma. November 7, 2019

Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinoma. November 7, 2019

Renal surgery for the older population: time for a paradigm shift? Data from the RESURGE project. November 7, 2019

ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis. November 6, 2019

Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma. November 6, 2019

Is partial nephrectomy worthwhile over radical nephrectomy for localised renal cortical tumours less than 7 cm in geriatric patients? November 6, 2019

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. November 5, 2019

Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis. November 5, 2019

Expression of Ring Box-1 protein and its relationship with Fuhrman grade and other clinical-pathological parameters in renal cell cancer. November 5, 2019

Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study. November 4, 2019

Negative Effect of Immediate Sunitinib Interruption on Survival in Patients With Metastatic Renal Cell Carcinoma. November 4, 2019

Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors. November 4, 2019

Clinical utility of contrast-enhanced ultrasonography in the diagnosis of benign and malignant small renal masses among Asian population. November 1, 2019

Safe use of nivolumab in a patient with renal cell carcinoma and hepatitis B. November 1, 2019

Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy. November 1, 2019

Page 161 of 456